Morphic Holding, Inc. Common Stock

MORF

...

MORF: Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.

Show MORF Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of MORF by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by MORF's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on MORF's company Twitter account

WallStreetBets

Number of mentions of MORF in WallStreetBets Daily Discussion

MORF News

Recent insights relating to MORF

CNBC Recommendations

Recent picks made for MORF stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MORF

Corporate Flights

Flights by private jets registered to MORF